Product Name :
Zoniporide hydrochloride
Description:
Zoniporide (CP-597396) hydrochloride is a potent and selective inhibitor of sodium-hydrogen exchanger type 1 (NHE-1). Zoniporide hydrochloride inhibits human NHE-1 (IC50=14 nM), and has >150-fold selectivity versus other NHE isoforms. Zoniporide hydrochloride potently inhibits ex vivo NHE-1-dependent swelling of human platelets (IC50=59 nM).
CAS:
241800-97-5
Molecular Weight:
356.81
Formula:
C17H17ClN6O
Chemical Name:
5-cyclopropyl-N-(diaminomethylidene)-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide hydrochloride
Smiles :
Cl.NC(N)=NC(=O)C1C=NN(C=1C1CC1)C1=CC=CC2=NC=CC=C21
InChiKey:
JTEXNYIOROVPIR-UHFFFAOYSA-N
InChi :
InChI=1S/C17H16N6O.ClH/c18-17(19)22-16(24)12-9-21-23(15(12)10-6-7-10)14-5-1-4-13-11(14)3-2-8-20-13;/h1-5,8-10H,6-7H2,(H4,18,19,22,24);1H
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Zoniporide (CP-597396) hydrochloride is a potent and selective inhibitor of sodium-hydrogen exchanger type 1 (NHE-1). Zoniporide hydrochloride inhibits human NHE-1 (IC50=14 nM), and has >150-fold selectivity versus other NHE isoforms. Zoniporide hydrochloride potently inhibits ex vivo NHE-1-dependent swelling of human platelets (IC50=59 nM).|Product information|CAS Number: 241800-97-5|Molecular Weight: 356.81|Formula: C17H17ClN6O|Chemical Name: 5-cyclopropyl-N-(diaminomethylidene)-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide hydrochloride|Smiles: Cl.NC(N)=NC(=O)C1C=NN(C=1C1CC1)C1=CC=CC2=NC=CC=C21|InChiKey: JTEXNYIOROVPIR-UHFFFAOYSA-N|InChi: InChI=1S/C17H16N6O.{{18:0 mPEG2000 PE} web|{18:0 mPEG2000 PE} Metabolic Enzyme/Protease|{18:0 mPEG2000 PE} Activator|{18:0 mPEG2000 PE} Biological Activity|{18:0 mPEG2000 PE} Formula|{18:0 mPEG2000 PE} supplier} ClH/c18-17(19)22-16(24)12-9-21-23(15(12)10-6-7-10)14-5-1-4-13-11(14)3-2-8-20-13;/h1-5,8-10H,6-7H2,(H4,18,19,22,24);1H|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Luseogliflozin} site|{Luseogliflozin} SGLT|{Luseogliflozin} Purity & Documentation|{Luseogliflozin} Data Sheet|{Luseogliflozin} custom synthesis|{Luseogliflozin} Cancer} |Shelf Life: ≥12 months if stored properly.PMID:27217159 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Zoniporide (0.25-4 mg/kg; i.v.; every hour for 2 hours) elicits a dose-dependent reduction in infarct size (ED50=0.45 mg/kg/h) in open chest anesthetized rabbits. Zoniporide exhibits moderate plasma protein binding, has a t1/2 of 1.5 hours in monkeys, and has one major active metabolite. Zoniporide treatment shows the AUC0-∞ and t1/2 are 0.07 μg h/mL and 0.5 hours, respectively.|Products are for research use only. Not for human use.|